Form EFFECT ABVC BIOPHARMA, INC.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 20, 2025 |
| Accession Number: | 0001213900-25-044880 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marquette National Corporation Reports Third Quarter 2026 Results
- Form 8.5 (EPT/RI) - Pharos Energy Plc
- Aeson Power Demonstrates the Versatility of Sodium-Ion Technology at All Energy Australia 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share